Gordon G. Carmichael's most recent trade in Gyre Therapeutics Inc was a trade of 26,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gyre Therapeutics Inc | Gordon G. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Gordon G. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 52,000 | 52,000 | - | - | Stock Option (Right to Buy) |